193 related articles for article (PubMed ID: 37869587)
1. Retracted: Development and Validation of a Novel Mitophagy-Related Gene Prognostic Signature for Hepatocellular Carcinoma Based on Immunoscore Classification of Tumor.
Oncology JO
J Oncol; 2023; 2023():9803262. PubMed ID: 37869587
[TBL] [Abstract][Full Text] [Related]
2. Development and Validation of a Novel Mitophagy-Related Gene Prognostic Signature for Hepatocellular Carcinoma Based on Immunoscore Classification of Tumor.
Chen H; Wang J; Zeng R; Luo Y; Guo K; Wu H; Yang Q; Jiang R; Sha W; Zhuo Z
J Oncol; 2021; 2021():5070099. PubMed ID: 34733329
[TBL] [Abstract][Full Text] [Related]
3. A novel immune-related genes prognosis biomarker for hepatocellular carcinoma.
Wang K; Chen X; Jin C; Mo J; Jiang H; Yi B; Chen X
Aging (Albany NY); 2020 Nov; 13(1):675-693. PubMed ID: 33260154
[TBL] [Abstract][Full Text] [Related]
4. Retracted: Establishment and Validation of an MTORC1 Signaling-Related Gene Signature to Predict Overall Survival in Patients with Hepatocellular Carcinoma.
International BR
Biomed Res Int; 2024; 2024():9851737. PubMed ID: 38549990
[TBL] [Abstract][Full Text] [Related]
5. Significance of tumor-infiltrating immunocytes for predicting prognosis of hepatitis B virus-related hepatocellular carcinoma.
Chen QF; Li W; Wu PH; Shen LJ; Huang ZL
World J Gastroenterol; 2019 Sep; 25(35):5266-5282. PubMed ID: 31558872
[TBL] [Abstract][Full Text] [Related]
6. Retracted: Development of a Bile Acid-Related Gene Signature for Predicting Survival in Patients with Hepatocellular Carcinoma.
Methods In Medicine CAM
Comput Math Methods Med; 2023; 2023():9865740. PubMed ID: 38094394
[TBL] [Abstract][Full Text] [Related]
7. Retracted: Identification and Validation of an Inflammatory Response-Related Polygenic Risk Score as a Prognostic Marker in Hepatocellular Carcinoma.
Markers D
Dis Markers; 2023; 2023():9809678. PubMed ID: 37538093
[TBL] [Abstract][Full Text] [Related]
8. A Mitophagy-Related Gene Signature for Subtype Identification and Prognosis Prediction of Hepatocellular Carcinoma.
Liu C; Wu Z; Wang L; Yang Q; Huang J; Huang J
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36292980
[TBL] [Abstract][Full Text] [Related]
9. A novel prognostic immunoscore based on The Cancer Genome Atlas to predict overall survival in colorectal cancer patients.
Tang Z; Wu Y; Sun D; Xue X; Qin L
Biosci Rep; 2021 Oct; 41(10):. PubMed ID: 34608935
[TBL] [Abstract][Full Text] [Related]
10. Retracted: New Pyroptosis-Associated Gene Signature for Overall Survival Forecast among Patients Suffering from Hepatocellular Carcinoma.
Healthcare Engineering JO
J Healthc Eng; 2023; 2023():9809725. PubMed ID: 37621615
[TBL] [Abstract][Full Text] [Related]
11. A nomogram based on collagen signature for predicting the immunoscore in colorectal cancer.
Jiang W; Yu X; Dong X; Long C; Chen D; Cheng J; Yan B; Xu S; Lin Z; Chen G; Zhuo S; Yan J
Front Immunol; 2023; 14():1269700. PubMed ID: 37781377
[TBL] [Abstract][Full Text] [Related]
12. International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study.
Pagès F; Mlecnik B; Marliot F; Bindea G; Ou FS; Bifulco C; Lugli A; Zlobec I; Rau TT; Berger MD; Nagtegaal ID; Vink-Börger E; Hartmann A; Geppert C; Kolwelter J; Merkel S; Grützmann R; Van den Eynde M; Jouret-Mourin A; Kartheuser A; Léonard D; Remue C; Wang JY; Bavi P; Roehrl MHA; Ohashi PS; Nguyen LT; Han S; MacGregor HL; Hafezi-Bakhtiari S; Wouters BG; Masucci GV; Andersson EK; Zavadova E; Vocka M; Spacek J; Petruzelka L; Konopasek B; Dundr P; Skalova H; Nemejcova K; Botti G; Tatangelo F; Delrio P; Ciliberto G; Maio M; Laghi L; Grizzi F; Fredriksen T; Buttard B; Angelova M; Vasaturo A; Maby P; Church SE; Angell HK; Lafontaine L; Bruni D; El Sissy C; Haicheur N; Kirilovsky A; Berger A; Lagorce C; Meyers JP; Paustian C; Feng Z; Ballesteros-Merino C; Dijkstra J; van de Water C; van Lent-van Vliet S; Knijn N; Mușină AM; Scripcariu DV; Popivanova B; Xu M; Fujita T; Hazama S; Suzuki N; Nagano H; Okuno K; Torigoe T; Sato N; Furuhata T; Takemasa I; Itoh K; Patel PS; Vora HH; Shah B; Patel JB; Rajvik KN; Pandya SJ; Shukla SN; Wang Y; Zhang G; Kawakami Y; Marincola FM; Ascierto PA; Sargent DJ; Fox BA; Galon J
Lancet; 2018 May; 391(10135):2128-2139. PubMed ID: 29754777
[TBL] [Abstract][Full Text] [Related]
13. Retracted: Ferroptosis-Related lncRNA for the Establishment of Novel Prognostic Signature and Therapeutic Response Prediction to Endometrial Carcinoma.
International BR
Biomed Res Int; 2022; 2022():9829634. PubMed ID: 36605105
[TBL] [Abstract][Full Text] [Related]
14. Retracted: Prediction of Hepatocellular Carcinoma Prognosis and Immune Cell Infiltration Using Gene Signature Associated with Inflammatory Response.
Methods In Medicine CAM
Comput Math Methods Med; 2023; 2023():9759467. PubMed ID: 38094384
[TBL] [Abstract][Full Text] [Related]
15. Retracted: Identification of the HMMR Gene as a Diagnostic and Prognostic Biomarker in Hepatocellular Carcinoma Based on Integrated Bioinformatics Analysis.
And Alternative Medicine EC
Evid Based Complement Alternat Med; 2023; 2023():9819147. PubMed ID: 37808149
[TBL] [Abstract][Full Text] [Related]
16. Retracted: Identification of a Ferroptosis-Related Prognostic Signature in Sepsis via Bioinformatics Analyses and Experiment Validation.
International BR
Biomed Res Int; 2024; 2024():9785480. PubMed ID: 38550060
[TBL] [Abstract][Full Text] [Related]
17. Application of the Immunoscore as prognostic tool for hepatocellular carcinoma.
Petrizzo A; Buonaguro L
J Immunother Cancer; 2016; 4():71. PubMed ID: 27879973
[TBL] [Abstract][Full Text] [Related]
18. Prognostic and Predictive Value of an Immunoscore Signature in Glioblastoma Multiform.
Tang X; Xu P; Chen A; Deng G; Zhang S; Gao L; Dai L; Chen Q
Front Genet; 2020; 11():514363. PubMed ID: 33244317
[TBL] [Abstract][Full Text] [Related]
19. Pretreatment prediction of immunoscore in hepatocellular cancer: a radiomics-based clinical model based on Gd-EOB-DTPA-enhanced MRI imaging.
Chen S; Feng S; Wei J; Liu F; Li B; Li X; Hou Y; Gu D; Tang M; Xiao H; Jia Y; Peng S; Tian J; Kuang M
Eur Radiol; 2019 Aug; 29(8):4177-4187. PubMed ID: 30666445
[TBL] [Abstract][Full Text] [Related]
20. Retracted: Distinctive Metabolism-Associated Gene Clusters That Are Also Prognostic in Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma.
Longevity OMAC
Oxid Med Cell Longev; 2023; 2023():9815947. PubMed ID: 37565164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
